999精品在线视频,手机成人午夜在线视频,久久不卡国产精品无码,中日无码在线观看,成人av手机在线观看,日韩精品亚洲一区中文字幕,亚洲av无码人妻,四虎国产在线观看 ?

Associations of tea consumption with blood pressure progression and hypertension incidence

2021-09-05 01:20:14XiaoGeNIUCanCAIFangChaoLIUJianXinLIKeYongHUANGXueLiYANGJieCAOShuFengCHENHongFanLIChongSHENYingXinZHAODongShengHUShuJunGUJianFengHUANGXiangFengLUDongFengGU
Journal of Geriatric Cardiology 2021年8期

Xiao-Ge NIU ,Can CAI ,Fang-Chao LIU ,Jian-Xin LI ,Ke-Yong HUANG ,Xue-Li YANG ,Jie CAO,Shu-Feng CHEN,Hong-Fan LI,Chong SHEN,Ying-Xin ZHAO,Dong-Sheng HU,Shu-Jun GU,Jian-Feng HUANG,Xiang-Feng LU,,Dong-Feng GU,8

1.Department of Epidemiology,State Key Laboratory of Cardiovascular Disease,Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China;2.Tianjin Key Laboratory of Environment,Nutrition and Public Health,Department of Occupational and Environmental Health,School of Public Health,Tianjin Medical University,Tianjin,China;3.Department of Epidemiology and Biostatistics,School of Public Health,Nanjing Medical University,Nanjing,China;4.Cardio-Cerebrovascular Control and Research Center,Institute of Basic Medicine,Shandong First Medical University (Shandong Academy of Medical Sciences),Jinan,China;5.Department of Epidemiology and Health Statistics,College of Public Health,Zhengzhou University,Henan,China;6.Department of Biostatistics and Epidemiology,School of Public Health,Shenzhen University Health Science Centre,Shenzhen,China;7.Changshu Center for Disease Control and Prevention,Jiangsu,China;8.School of Medicine,Southern University of Science and Technology,Shenzhen,China

ABSTRACT BACKGROUND Association between tea consumption and incident hypertension remains uncertain.This study conducted to examine the health effects of tea consumption on blood pressure progression and hypertension incidence.METHODS A population-based cohort of 38,913 Chinese participants without hypertension at baseline were included in the current study.Information on tea consumption was collected through standardized questionnaires.Associations of tea consumption with blood pressure progression and incident hypertension were analyzed using logistic regression models and Cox proportional hazards regression models,respectively.RESULTS During a median follow-up of 5.9 years,17,657 individuals had experienced progression to a higher blood pressure stage and 5,935 individuals had developed hypertension.In multivariate analyses,habitual tea drinkers (≥ 3 times/week for at least six months) had a 17% lower risk for blood pressure progression [odds ratio (OR)=0.83,95% CI:0.79–0.88] and a 14% decreased risk for incident hypertension [hazard ratio (HR)=0.86,95% CI:0.80–0.91] compared with non-habitual tea drinkers.Individuals in different baseline blood pressure groups could obtain similar benefit from habitual tea drinking.In terms of tea consumption amount,an inverse,linear dose-response relation between monthly consumption of tea leaves and risk of blood pressure progression was observed,while the risk of incident hypertension did not reduce further after consuming around 100 g of tea leaves per month.CONCLUSIONS Our study demonstrated that habitual tea consumption could provide preventive effect against blood pressure progression and hypertension incidence.

Cardiovascular disease (CVD) is the leading cause of death in China.Hypertension is the most important risk factor for CVD that affects 23.2% of Chinese adults.[1]According to the Global Burden of Disease Study,high systolic blood pressure (SBP) was consistently responsible for the largest number of all-cause deaths,which accounted for 10.8 million deaths in 2019.[2]Furthermore,29.2% of global adult population were predicted to have hypertension and the number of adults with hypertension was predicted to be 1.56 billion in 2025.[3]Thus,it is essential to place high priority for hypertension prevention and control.

Tea is produced from hot water infusion of driedCamellia sinensisto create a flavonoid-rich beverage.As the second most frequently consumed beverage worldwide,tea has been regularly consumed for centuries in China.Given the high consumption of tea,it is important to understand its potential health effects in diverse populations.Over the past few decades,exploratory research has reported that tea may influence the risks of numerous diseases,including CVD,type 2 diabetes mellitus,and cancer.[4–6]Many epidemiological studies have shown that tea consumption was related to lower risk of CVD.[4,7,8]One potential mechanism is that tea consumption might lower blood pressure (BP),thereby mediating the protective effect of tea on CVD.However,existing evidence remains inconclusive as to the association between tea consumption and hypertension risk.[9–13]Relatively small sample sizes,cross-sectional design,and the absence of important covariates might have led to the varying results.Evidence related to this association from prospective investigations is still lacking.Therefore,large-scale prospective cohort studies are essential to investigate the associations of tea consumption with BP progression and hypertension incidence.

In the current study,we aimed to assess the longitudinal relationship of tea consumption with BP progression and incident hypertension among a prospective cohort of 38,913 Chinese adults.

METHODS

Study Population

Participants for the current study were from the Community Intervention of Metabolic Syndrome in China &Chinese Family Health Study (CIMIC).Details of study design and inclusion criteria for this study have been described elsewhere.[14]In brief,the CIMIC study was a large,community-based cohort established from 2007 to 2008.A cluster random sampling method was applied to select participants aged ≥ 18 years in Shandong,Henan,and Jiangsu provinces.A total of 86,428 participants were enrolled at baseline and invited to participate in the follow-up survey from 2012 to 2015.Of the original participants in the CIMIC study,80,929 participants were followed-up successfully (93.6%).We subsequently excluded 1,325 participants who reported a history of CVD or cancer at baseline,1,611 participants with missing data on tea drinking habits,30,511 participants with prevalent hypertension or missing BP information at baseline,and 8,569 participants with missing BP information at follow-up.Finally,38,913 participants were available for the current analyses (Figure 1).

Figure 1 Flowchart of study population inclusion and exclusion.

This study was approved by the Institutional Review Board at Fuwai Hospital in Beijing (No.2012-399).Informed consent was obtained from each participant prior to data collection.

Assessment of Tea Consumption and Covariates

At the baseline survey,all participants were asked to report their tea consumption habit during the past year through standardized questionnaires by trained and certificated staff.Tea drinking frequency was measured via the times of replacement of tea leaves or tea bags.Participants were asked whether they were habitual tea drinkers (≥ 3 times/week for at least six months) or not.We further collected information on monthly tea leaves consumption amount [dry weight,in Chinese liang (unit of weight equal to 50 g)] for habitual tea drinkers.

Information on socio-demographic characteristics,lifestyle risk factors,and family and personal medical history via standardized questionnaires were also collected at baseline.Body weight and height were measured with participants wearing only light clothes without shoes.Body mass index (BMI) was defined as the body weight divided by the square of the body height (kg/m2).A smoker was defined as someone who had consumed at least one cigarette daily for one year or more.An alcohol drinker was defined as someone who drank at least once weekly during the past year.Ideal physical activity was defined as at least 150 min of moderate physical activity or at least 75 min of vigorous physical activity per week.Family history of hypertension was considered positive if his/her parent or sibling were reported with hypertension.Blood samples were drawn from participants after fasting for at least ten hours to determine blood glucose and lipid levels.

Outcome Measures

We measured BP and collected data on antihypertensive drugs at baseline and follow-up visit.Trained investigators measured BP using an electronic BP monitor during the clinic or home visits generally in the morning,according to a common protocol recommended by the American Heart Association.[15]Participants were advised to avoid alcohol,cigarette smoking,coffee/tea,and exercise for at least 30 min before their BP measurement.BP was measured with the participant in the sitting position after at least 5 min of rest.An appropriate arm-cuff (pediatric,regular adult,large,or thigh)was chosen based on the circumference of participant’s arm and was placed on the right arm.BP measurements were repeated three times with a thirty-second interval between each measurement.The average of the three BP measurements was used in the analysis.

At baseline,three BP categories were defined as follows:(1) below 120 mmHg for SBP and 75 mmHg for diastolic blood pressure (DBP);(2) 120?129 mmHg for SBP or 75?84 mmHg for DBP;and (3) 130?139 mmHg for SBP or 85–89 mmHg for DBP.[16]To assess BP progression,we created categories of BP at follow-up identical to those at baseline.BP progression was defined by progressing at least one BP category compared with baseline or by a new diagnosis of hypertension during follow-up.Hypertension was defined as SBP ≥ 140 mmHg and/or DBP ≥90 mmHg and/or use of antihypertensive medication within the past two weeks.

Statistical Analysis

Baseline characteristics were described as mean ±SD for continuous variables or percentages for categorical variables.We constructed logistic regression models to examine the relationship between tea consumption and BP progression.Cox proportional hazards models were fitted to assess these relationships for incident hypertension.Person-years of follow-up were calculated from the date of baseline survey until the date of first hypertension diagnosis,or initial use of antihypertensive medication,or the date of last follow-up.Two separate models were constructed for these analyses:model 1 was adjusted for age,gender,BMI,region (north/south),and baseline SBP;model 2 was additionally adjusted for smoking (yes or no),drinking (yes or no),physical activity (ideal or not),education level (≥ 12 years or not),fasting blood glucose,total cholesterol,and family history of hypertension (yes or no).Trend tests were conducted by modeling the median of tea consumption amount of each category as a continuous variable.Dose-response relationships were assessed by restricted cubic spline analyses with 0 g/month consumption of tea leaves serving as the reference level.Nonlinear associations were checked firstly by using the likelihood ratio test.If tests for nonlinearity were significant,spline models were used to describe the overall association,otherwise,linear models were used.

Subgroup analyses by age,sex,BMI,and baseline BP levels were conducted,and an interaction term with tea consumption was tested to investigate the potential effect modification.Sensitivity analyses were conducted by excluding all participants suffering hypertension within the first year of followup.Data were analyzed using R software (version 3.6.0,R Foundation for Statistical Computing,Vienna,Austria) or SAS 9.4 (SAS Institute Inc,Cary,North Carolina,USA).All statistical tests were two-sided,withP-value <0.05 considered statistically significant.

RESULTS

Table 1 presented the baseline characteristics of the study participants,overall and according to tea drinking frequency.At baseline,the mean age of participants was 49.2 years,35.6% of participants were males and 22.1% of participants were smokers.Overall,25.6% of all participants reported drank tea≥ 3 times/week for at least six months.Habitual tea drinkers were more likely to be males,smokers,habitual alcohol drinkers and well-educated.

During a median follow-up of 5.9 years,17,657 individuals had experienced progression to a higher BP stage and 5,935 individuals developed incident hypertension.The associations of tea consumption with BP progression were illustrated in Table 2.Habitual tea consumption was associated with a 17%decreased risk of BP progression [odds ratio (OR)=0.83,95% CI:0.79?0.88] in the fully adjusted model.We also observed that monthly tea consumption amount was inversely associated with BP progression.Compared with non-habitual tea drinkers,those who consumed 50 g,100 g,and ≥ 150 g tea leaves per month were associated with 10%,13%,and 23% lower risk of BP progression (Ptrend<0.001),respectively.

Tea consumption also provided preventive effect against incident hypertension.Habitual tea consumption was associated with a 14% lower risk of incident hypertension [hazard ratio (HR)=0.86,95% CI:0.80?0.91] (Table 3).Compared with nonhabitual tea drinkers,the estimated HRs of incident hypertension were 0.95 (95% CI:0.85?1.07) for those who consumed 50 g/month of tea leaves,0.83 (95%CI:0.75?0.92) for those who consumed 100 g/month,and 0.83 (95% CI:0.76?0.91) for those who consumed ≥ 150 g/month.

We further plotted the dose-response curves for BP progression and hypertension incidence associated with monthly tea consumption amount.There was an inverse,and almost linear association between tea consumption amount and BP progression (Pnonlinear=0.438),whereas the decreasing risk for incident hypertension reached a flattening after consuming approximately 100 g/month of tea leaves (Pnonlinear=0.002) (Figure 2).

Figure 2 Dose-response relations of monthly tea leaves consumption with blood pressure progression and hypertension incidence. Odds ratios of blood pressure progression (A) and hazard ratios of incident hypertension (B) were estimated using a restrict cubic spline function by comparing to a reference value of 0 g/month.Solid line represents point estimate and dashed lines represent 95% confidence intervals.

The relationships of habitual tea consumptionwith BP progression and incident hypertension remained stable after excluding those with incident hypertension occurring within the first year of follow-up (Tables 4 &5).Analyses stratified by age,baseline BMI,and BP levels revealed similar effects of habitual tea consumption on BP progression and incident hypertension.We observed potential effect modifications by sex related to tea consumption,which presented a more pronounced association for BP progression among males and a stronger association for hypertension incidence among females(Table 6).

Table 1 Baseline characteristics of the study participants overall and according to tea drinking frequency.

Table 2 Odds ratios for risk of blood pressure progression associated with tea consumption.

Table 3 Hazard ratios for incident hypertension associated with tea consumption.

Table 4 Associations of tea consumption with blood pressure progression after excluding hypertension cases within the first year of follow-up.

Table 5 Associations of tea consumption with incident hypertension after excluding hypertension cases within the first year of follow-up.

Table 6 Subgroup analyses for blood pressure progression and incident hypertension associated with habitual tea drinking by specific characteristics.

DISCUSSION

In this large prospective cohort study of 38,913 participants in China,we found that habitual tea drinkers had 17% and 14% lower risk of BP progression and hypertension incidence,compared with non-habitual tea drinkers.The health benefits of habitual tea consumption on BP progression and hypertension were similar across different baseline BP categories.There was a progressive reduction in risk of BP progression associated with higher amount of monthly tea consumption.The current study suggests that tea might be a healthy beverage for primary prevention against BP progression and hypertension.

The available epidemiologic evidence on tea intake related to hypertension is inconclusive.Several cross-sectional studies have assessed the relationship between tea consumption,BP,and hypertension.For example,the Observation of Cardiovascular Risk Factors study in Luxembourg (ORISCAV-LUX)with 1,352 individuals showed daily consumption of 1 dL of tea was associated with a significant reduction of SBP by 0.6 mmHg and pulse pressure by 0.5 mmHg.[10]Another cross-sectional study observed that habitual green or oolong tea consumption (120 mL/day or more) for at least one year was associated with decreased risk of hypertension prevalence in a population of 1,507 subjects in Taiwan,China.[9]Additionally,one study conducted in Jiangsu,China with 4,579 older adults also found that habitual tea drinking was inversely associated with SBP values and prevalence of hypertension.[11]Although many of these studies report a significant inverse association of tea with BP or hypertension,evidences from prospective cohort studies remain scarce.A cohort study of 1,878 Iran adult with sixyear follow-up observed no significant association between tea intake and the risk of hypertension.[13]The Singapore Chinese Health Study with 9.5 years of follow-up among 38,592 participants found that daily consumption of black tea or green tea might cause higher risk of hypertension,and this association was attenuated and became non-significant after adjusting for caffeine intake.[12]This study used the number of cups of tea as the measure of exposure and self-reported hypertension as the measure of outcome,which may lead to misclassifications due to the high unawareness rate of hypertension in Singapore (43.1%).[17]In contrast,our study provided substantial evidence about health benefits of tea consumption on both BP progression and hypertension incidence through standardized clinical measurements of BP.

In the current prospective cohort study with a duration of 5.9-year follow-up in China,we observed that habitual tea consumption was associ-ated with a reduced risk of both BP progression and hypertension.It was notable that individuals with prehypertension could obtain the similar benefits as those with ideal BP.Several prior cohort studies supported the protective effects of tea consumption on cardiometabolic diseases.Our recent study showed that habitual tea drinkers had 20%,22%,and 15% lower risk of CVD incidence,CVD mortality,and all-cause mortality,respectively,compared with non-habitual tea drinkers.[4]The Dongfeng-Tongji cohort study found that green tea consumption could reduce the risk of coronary heart disease incidence (HR=0.89,95% CI:0.81?0.98) and improve blood lipid and uric acid levels.[18]A metaanalysis of nine cohort studies revealed that tea consumption ≥ 4 cups per day (relative risk=0.80,95% CI:0.70?0.93) might play a role in the prevention of type 2 diabetes mellitus.[19]Besides habitual tea drinking frequency these studies focused on,we further examined the linear dose-response relation between tea consumption amount and BP progression.We found that individuals who consumed ≥50 g tea leaves per month could achieve benefit for both BP progression and hypertension incidence,whereas the risk of incident hypertension did not reduce further after around 100 g/month of tea consumption.The threshold of monthly tea consumption amount benefitting cardiovascular health was similar to that in the China Kadoorie Biobank,which demonstrated that daily consumption of ≥ 2 g tea(being equivalent to 60 g/month) could reduce the risk of stroke incidence.[20]Further studies in large prospective cohorts are needed to confirm the doseresponse relation.

The findings that tea consumption was associated with lower risk of BP progression and incident hypertension are biologically reasonable.Tea contains a variety of antioxidants and other chemicals(flavonoids,theaflavins,thearubigins,and polyphenols,etc.) that have endothelial protection and anti-inflammatory effects.[21]Tea flavonoids can act as modulators of enzymes involved in oxidative and inflammatory stress,enhance nitric oxide status,and improve endothelial function,which may contribute to potential benefits on cardiovascular health.[22]During last decades,in vitroand animal studies indicated that potentially beneficial effects of tea polyphenols mainly due to its antioxidant properties and bioactivity on scavenging free radicals,promoting lipid metabolism and maintaining stability of vascular endothelium.[23–26]There were also some randomized controlled trials in humans which observed an inverse association between tea and BP.A meta-analysis of twenty-one randomized trials showed that after long-term tea intake (≥ 1 week),the pooled mean SBP and DBP were lower by 1.8 mmHg (95% CI:1.1?2.4) and 1.4 mmHg (95% CI:0.6?2.2),respectively.[27]

STRENGTHS AND LIMITATION

To our knowledge,this is the first longitudinal study to evaluate the effects of tea consumption on the risk of BP progression and hypertension incidence in China.The strengths of our study included the prospective study design,large sample size,and the collection of a broad range of covariates at individual level.Furthermore,we also measured tea consumption in grams of dry tea leaves which may better reflect the actual ingested tea components.In addition,we assessed outcome by standardized clinical measurements of BP,which could be more precise than self-reported hypertension.Several limitations of the current study should also be noted.On the one hand,since information on tea consumption and the covariates,such as physical activity,were self-reported,inevitable recall bias might result in misclassification.However,possible measurement errors would have most likely been nondifferential and biased the results towards the null.On the other hand,tea drinking habit may change over time and lead to underestimation of the true association.

CONCLUSIONS

In conclusion,habitual tea consumption could reduce the risk for both BP progression and hypertension in China.These results gave us a further insight into the role of tea consumption in cardiovascular health and indicated that tea might be a healthy beverage worth of popularizing.

ACKNOWLEDGMENTS

This study was supported by the National Nature Science Foundation of China (No.91643208),the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2017-I2M-1-004 &2019-I2M-2-003),and the National Key Research &Development Program of China (2017YFC0211700 &2018YFE0115300).All authors had no conflicts of interest to disclose.

主站蜘蛛池模板: 久久久精品无码一二三区| 亚洲系列无码专区偷窥无码| 国产v欧美v日韩v综合精品| 国产美女在线观看| 亚洲一区无码在线| 波多野结衣的av一区二区三区| 亚欧成人无码AV在线播放| 热伊人99re久久精品最新地| 99精品伊人久久久大香线蕉 | 天天综合网色| 欧美成在线视频| 99久久99视频| 国产91成人| 男女性色大片免费网站| 2022国产91精品久久久久久| 老色鬼欧美精品| 视频国产精品丝袜第一页| 国产真实自在自线免费精品| 不卡无码h在线观看| 天堂在线视频精品| 在线无码av一区二区三区| 超碰aⅴ人人做人人爽欧美 | 色综合狠狠操| 国产成人欧美| 日韩成人在线视频| 国产伦精品一区二区三区视频优播| 国产不卡网| 日韩精品无码免费专网站| 狼友av永久网站免费观看| 欧美日韩亚洲综合在线观看| 精品一区二区三区水蜜桃| 成人免费黄色小视频| 久久无码高潮喷水| 女人18毛片水真多国产| 1769国产精品视频免费观看| 丁香五月激情图片| 波多野结衣AV无码久久一区| 国产精品专区第一页在线观看| 特级做a爰片毛片免费69| 国产在线视频二区| 国产视频a| 亚洲αv毛片| 久久这里只有精品66| 亚洲综合九九| 香蕉伊思人视频| 亚洲国产中文在线二区三区免| 国产亚洲高清视频| AV天堂资源福利在线观看| 91亚洲精选| 国产日本欧美亚洲精品视| 精品无码一区二区三区电影| 欧美另类图片视频无弹跳第一页| 制服丝袜一区二区三区在线| 在线播放真实国产乱子伦| 欧美一区二区啪啪| 色婷婷亚洲综合五月| 伊人色在线视频| 91麻豆精品国产高清在线| 亚洲中文制服丝袜欧美精品| 国产九九精品视频| 在线免费a视频| 谁有在线观看日韩亚洲最新视频| 日韩人妻精品一区| 精品伊人久久久香线蕉| 67194成是人免费无码| 性激烈欧美三级在线播放| a级毛片免费在线观看| 日韩东京热无码人妻| 在线精品亚洲一区二区古装| 57pao国产成视频免费播放| 91伊人国产| 亚洲第一视频免费在线| 亚洲国产91人成在线| 国产成人福利在线视老湿机| 色综合中文| 日韩国产综合精选| 青青久久91| 五月婷婷丁香色| 亚洲日本www| 美女被操黄色视频网站| 亚洲国产av无码综合原创国产| 欧美高清日韩|